Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2633461000168110 | canakinumab 150 mg / 1 mL injection, 1 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2633471000168116 | canakinumab 150 mg/mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| canakinumab 150 mg/mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| canakinumab 150 mg/mL injection, vial | Is a | canakinumab | true | Inferred relationship | Some | ||
| canakinumab 150 mg/mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| canakinumab 150 mg/mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 429916613 | |
| canakinumab 150 mg/mL injection, vial | has Australian BoSS | canakinumab | true | Inferred relationship | Some | 429916612 | |
| canakinumab 150 mg/mL injection, vial | has intended active ingredient | canakinumab | true | Inferred relationship | Some | 429916612 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Canakinumab (Novartis) (canakinumab 150 mg / 1 mL) injection, 1 mL vial (trade product unit of use) | Is a | True | canakinumab 150 mg/mL injection, vial | Inferred relationship | Some | |
| canakinumab 150 mg/mL injection, 1 mL vial | has MPUU | True | canakinumab 150 mg/mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR